Diabetes and driving: towards equitable, evidence-based decision-making.
In January 1998, the British government introduced new restrictions on licensing of people with insulin-treated diabetes mellitus to drive. These restrictions were based on the second EU driver licensing directive (91/4389) and looked to be costing insulin-treated diabetic individuals their entitlement to drive light goods and small passenger-carrying vehicles. In response to concerns expressed by the diabetes community in Britain, the British Diabetic Association commissioned a report examining and interpreting the available evidence of accident risk in insulin-treated diabetic patients, particularly that related to unexpected hypoglycaemia. The following article is drawn from that report.
MacLeod
K M
KM
Department of Diabetes and Vascular Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter, UK.
D000063:Accidents, Traffic; D001333:Automobile Driver Examination; D003922:Diabetes Mellitus, Type 1; D006233:Persons with Disabilities; D005062:European Union; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D012307:Risk Factors; D006113:United Kingdom